BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 30207193)

  • 1. Chemical angioplasty for medically refractory reversible cerebral vasoconstriction syndrome
    Al-Mufti F; Dodson V; Wajswol E; El-Ghanem M; Alchaki A; Nuoman R; Thabet A; Sutherland A; Roychowdhury S; Hidalgo A; Gupta G
    Br J Neurosurg; 2018 Aug; 32(4):431-435. PubMed ID: 30207193
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intra-arterial milrinone for reversible cerebral vasoconstriction syndrome.
    Bouchard M; Verreault S; Gariépy JL; Dupré N
    Headache; 2009 Jan; 49(1):142-5. PubMed ID: 18647181
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ultrahigh-dose intraarterial infusion of verapamil through an indwelling microcatheter for medically refractory severe vasospasm: initial experience. Clinical article.
    Albanese E; Russo A; Quiroga M; Willis RN; Mericle RA; Ulm AJ
    J Neurosurg; 2010 Oct; 113(4):913-22. PubMed ID: 19877802
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intra-arterial application of nimodipine in reversible cerebral vasoconstriction syndrome: a diagnostic tool in select cases?
    Linn J; Fesl G; Ottomeyer C; Straube A; Dichgans M; Bruckmann H; Pfefferkorn T
    Cephalalgia; 2011 Jul; 31(10):1074-81. PubMed ID: 21220377
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reversible cerebral vasoconstriction syndrome: treatment with combined intra-arterial verapamil infusion and intracranial angioplasty.
    Farid H; Tatum JK; Wong C; Halbach VV; Hetts SW
    AJNR Am J Neuroradiol; 2011; 32(10):E184-7. PubMed ID: 21273351
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reversible cerebral vasoconstriction syndrome: treatment with multiple sessions of intra-arterial nimodipine and angioplasty.
    Ioannidis I; Nasis N; Agianniotaki A; Katsouda E; Andreou A
    Interv Neuroradiol; 2012 Sep; 18(3):297-302. PubMed ID: 22958768
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel approach to diagnose reversible cerebral vasoconstriction syndrome: a case series.
    Kass-Hout T; Kass-Hout O; Sun CH; Kass-Hout T; Ramakrishnan P; Nahab F; Nogueira R; Gupta R
    J Stroke Cerebrovasc Dis; 2015 Jan; 24(1):e31-7. PubMed ID: 25440342
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intra-Arterial Verapamil Treatment in Oral Therapy-Refractory Reversible Cerebral Vasoconstriction Syndrome.
    Ospel JM; Wright CH; Jung R; Vidal LLM; Manjila S; Singh G; Heck DV; Ray A; Blackham KA
    AJNR Am J Neuroradiol; 2020 Feb; 41(2):293-299. PubMed ID: 31879333
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reversible cerebral vasoconstriction syndrome: a complicated clinical course treated with intra-arterial application of nimodipine.
    Elstner M; Linn J; Müller-Schunk S; Straube A
    Cephalalgia; 2009 Jun; 29(6):677-82. PubMed ID: 19239677
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Repetitive use of intra-arterial verapamil in the treatment of reversible cerebral vasoconstriction syndrome.
    French KF; Hoesch RE; Allred J; Wilder M; Smith AG; Digre KB; La Barge DV
    J Clin Neurosci; 2012 Jan; 19(1):174-6. PubMed ID: 22118796
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improvement in angiographic cerebral vasospasm after intra-arterial verapamil administration.
    Sehy JV; Holloway WE; Lin SP; Cross DT; Derdeyn CP; Moran CJ
    AJNR Am J Neuroradiol; 2010 Nov; 31(10):1923-8. PubMed ID: 20705701
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reversible cerebral vasoconstriction syndrome (RCVS) in antiphospholipid antibody syndrome (APLA): the role of centrally acting vasodilators. Case series and review of literature.
    Gupta S; Zivadinov R; Ramasamy D; Ambrus JL
    Clin Rheumatol; 2014 Dec; 33(12):1829-33. PubMed ID: 24277114
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Duration of Vasodilatory Action After Intra-arterial Infusions of Calcium Channel Blockers in Animal Model of Cerebral Vasospasm.
    Lim J; Cho YD; Kwon HJ; Byoun SH; Koh HS; Park B; Choi SW
    Neurocrit Care; 2021 Jun; 34(3):867-875. PubMed ID: 32978731
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Verapamil in the treatment of reversible cerebral vasoconstriction syndrome: A systematic review.
    Collins L; Lam L; Kleinig O; Proudman W; Zhang R; Bagster M; Kovoor J; Gupta A; Goh R; Bacchi S; Schultz D; Kleinig T
    J Clin Neurosci; 2023 Jul; 113():130-141. PubMed ID: 37267876
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Continuous intra-arterial nimodipine for the treatment of cerebral vasospasm.
    Mayer TE; Dichgans M; Straube A; Birnbaum T; Müller-Schunk S; Hamann GF; Schulte-Altedorneburg G
    Cardiovasc Intervent Radiol; 2008; 31(6):1200-4. PubMed ID: 18446409
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A case of reversible cerebral vasoconstriction syndrome presenting with recurrent neurological deficits: Evaluation using noninvasive arterial spin labeling MRI.
    Komatsu T; Kimura T; Yagishita A; Takahashi K; Koide R
    Clin Neurol Neurosurg; 2014 Nov; 126():96-8. PubMed ID: 25238101
    [No Abstract]   [Full Text] [Related]  

  • 17. Continuous intra-arterial dilatation with nimodipine and milrinone for refractory cerebral vasospasm.
    Anand S; Goel G; Gupta V
    J Neurosurg Anesthesiol; 2014 Jan; 26(1):92-3. PubMed ID: 23774116
    [No Abstract]   [Full Text] [Related]  

  • 18. Catastrophic reversible cerebral vasoconstriction syndrome associated with serotonin syndrome.
    John S; Donnelly M; Uchino K
    Headache; 2013 Oct; 53(9):1482-7. PubMed ID: 24001215
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Continuous intra-arterial nimodipine infusion in patients with severe refractory cerebral vasospasm after aneurysmal subarachnoid hemorrhage: a feasibility study and outcome results.
    Bele S; Proescholdt MA; Hochreiter A; Schuierer G; Scheitzach J; Wendl C; Kieninger M; Schneiker A; Bründl E; Schödel P; Schebesch KM; Brawanski A
    Acta Neurochir (Wien); 2015 Dec; 157(12):2041-50. PubMed ID: 26439105
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reversible cerebral vasoconstriction syndrome successfully treated by intrathecal nicardipine.
    Zeitouni D; Parish JM; Smith M; Stetler WR; Bernard JD
    Clin Neurol Neurosurg; 2021 Jul; 206():106705. PubMed ID: 34053805
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.